Medicare Enrolled
Dr. Magued Fadly, M.D.
Pain Medicine · Woodland Hills, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fadly from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fadly?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fadly
Dr. Magued Fadly is a pain medicine specialist in Woodland Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Fadly performed 1,430 Medicare services across 621 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fadly received a total of $5,748 from 31 pharmaceutical and/or device companies across 223 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fadly is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 33% volume in CA
$5,748 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,430
Medicare services
Top 33% in CA for pain medicine
621
Unique beneficiaries
$171
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~75 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Spinal injection of contrast dye A contrast dye is injected into a specific level of the lower spine to help visualize the area during imaging. |
542 | $195 | $4,055 |
| Spinal injection of contrast for imaging A contrast dye is injected into a specific level of the middle or upper spine to enhance imaging studies. This helps visualize the spinal structures more clearly during the diagnostic procedure. |
327 | $178 | $3,740 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
86 | $91 | $450 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
81 | $192 | $3,975 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
51 | $181 | $3,078 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
51 | $98 | $2,794 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
38 | $147 | $550 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
31 | $201 | $3,806 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
31 | $102 | $3,565 |
| New patient office visit, complex (60-74 min) | 31 | $177 | $600 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
25 | $303 | $3,000 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
25 | $143 | $2,000 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
19 | $78 | $12,000 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
17 | $56 | $9,900 |
| Additional spine nerve root injection with imaging An anesthetic and/or steroid medication is injected into an additional nerve root in the upper or middle spine. The procedure uses imaging guidance to ensure accurate placement. |
17 | $115 | $1,824 |
| Spinal nerve root injection with imaging guidance An injection of anesthetic or steroid medication into a single nerve root in the upper or middle spine. The procedure uses imaging guidance to ensure accurate placement. |
16 | $181 | $2,781 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
14 | $62 | $1,300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $136 | $500 |
| Online digital E/M service, established patient, 21+ minutes An online digital evaluation and management service for an established patient. This service requires a total time of 21 or more minutes over a period of up to 7 days. |
14 | $38 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,748
Total received (2018-2024)
Avg $821/year across 7 years
Top 28% in CA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
223
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,748 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$57
2023
$358
2022
$1,535
2021
$843
2020
$514
2019
$1,140
2018
$1,300
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$35
Medtronic, Inc.
$23
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic USA, Inc.
$1,194
Medtronic, Inc.
$999
Collegium Pharmaceutical, Inc.
$730
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$473
Indivior Inc.
$436
ARBOR PHARMACEUTICALS, INC.
$299
Biohaven Pharmaceuticals, Inc.
$240
Nevro Corp.
$204
Boston Scientific Corporation
$195
Daiichi Sankyo Inc.
$144
Abbott Laboratories
$95
Merck Sharp & Dohme LLC
$90
Virtus Pharmaceuticals LLC
$82
Horizon Therapeutics plc
$59
Eisai Inc.
$47
AstraZeneca Pharmaceuticals LP
$46
DePuy Synthes Sales Inc.
$46
Merck Sharp & Dohme Corporation
$38
Vertical Pharmaceuticals, LLC
$37
IBSA Pharma Inc.
$35
Biohaven Pharmaceutical Holding Company Ltd.
$34
Kowa Pharmaceuticals America, Inc.
$34
Stryker Corporation
$33
Avanos Medical
$28
Shionogi Inc
$25
EISAI INC.
$25
PFIZER INC.
$23
Ethicon US, LLC
$16
BioDelivery Sciences International, Inc.
$14
Arbor Pharmaceuticals, Inc.
$14
Amgen Inc.
$13
Top 3 companies account for 50.8% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · Aimovig · BELBUCA · BELSOMRA · Belbuca · Dayvigo · GENERAL PAIN MANAGEMENT · GENERATOR · Horizant · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - IVAS · IVS - VERTEBRAL AUGMENTATION PRODUCTS · LACTULOSE · LEVORPHANOL TARTRATE · LORZONE · LUCEMYRA · LYRICA · Licart · MONOVISC · MOVANTIK · Morphabond ER · N'VISION · NURTEC ODT · Nucynta · Omnia · PENNSAID · Proclaim Family of SCS IPGs · RELISTOR · SEGLENTIS · SPECTRA WAVEWRITER · STRATAFIX · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUPERION · Senza Spinal Cord Stimulation System · Symproic · TARGETSTIM · VANTA ADAPTIVESTIM · Vanta · XTAMPZA · XTAMPZAER
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pain medicines within 10 mi
97
Per 100K population
1.0
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - WOODLAND HILLS
2.0 mi
2.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fadly is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fadly experienced with spinal injection of contrast dye?
Based on Medicare claims data, Dr. Fadly performed 542 spinal injection of contrast dye services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fadly receive payments from pharmaceutical companies?
Yes. Dr. Fadly received a total of $5,748 from 31 companies across 223 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fadly's costs compare to other pain medicines in Woodland Hills?
Dr. Fadly's average Medicare payment per service is $171. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fadly) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Woodland Hills
Browse pain medicines in Woodland Hills ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in CA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in CA
Which CA pain medicines receive the most from drug and device companies.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Collegium Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Collegium Pharmaceutical, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology